Graves' orbitopathy: a multidisciplinary approach - questions and answers ; 41 tables
Saved in:
| Format: | Book |
|---|---|
| Language: | English |
| Published: |
Basel [u.a.]
Karger
2010
|
| Edition: | 2., rev. ed. |
| Subjects: | |
| Online Access: | Inhaltsverzeichnis |
| Physical Description: | XV, 285 S. Ill., graph. Darst. |
| ISBN: | 9783805595315 |
Staff View
MARC
| LEADER | 00000nam a2200000 c 4500 | ||
|---|---|---|---|
| 001 | BV036657087 | ||
| 003 | DE-604 | ||
| 005 | 20101221 | ||
| 007 | t | ||
| 008 | 100907s2010 gw ad|| |||| 00||| eng d | ||
| 015 | |a 10,N23 |2 dnb | ||
| 016 | 7 | |a 1003053637 |2 DE-101 | |
| 020 | |a 9783805595315 |9 978-3-8055-9531-5 | ||
| 024 | 3 | |a 9783805595315 | |
| 035 | |a (OCoLC)671344907 | ||
| 035 | |a (DE-599)DNB1003053637 | ||
| 040 | |a DE-604 |b ger |e rakddb | ||
| 041 | 0 | |a eng | |
| 044 | |a gw |c XA-DE-BW | ||
| 049 | |a DE-12 |a DE-355 | ||
| 082 | 0 | |a 617.74 |2 22/ger | |
| 084 | |a YO 3647 |0 (DE-625)153942:12954 |2 rvk | ||
| 084 | |a 610 |2 sdnb | ||
| 245 | 1 | 0 | |a Graves' orbitopathy |b a multidisciplinary approach - questions and answers ; 41 tables |c ed.: Wilmar M. Wiersinga ... |
| 250 | |a 2., rev. ed. | ||
| 264 | 1 | |a Basel [u.a.] |b Karger |c 2010 | |
| 300 | |a XV, 285 S. |b Ill., graph. Darst. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 650 | 0 | 7 | |a Endokrine Ophthalmopathie |0 (DE-588)4196103-1 |2 gnd |9 rswk-swf |
| 655 | 7 | |0 (DE-588)4143413-4 |a Aufsatzsammlung |2 gnd-content | |
| 689 | 0 | 0 | |a Endokrine Ophthalmopathie |0 (DE-588)4196103-1 |D s |
| 689 | 0 | |5 DE-604 | |
| 700 | 1 | |a Wiersinga, Wilmar M. |e Sonstige |4 oth | |
| 776 | 0 | 8 | |i Erscheint auch als |n Online-Ausgabe |z 978-3-8055-9532-2 |
| 856 | 4 | 2 | |m DNB Datenaustausch |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=020576468&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-020576468 | ||
Record in the Search Index
| _version_ | 1804143275826741248 |
|---|---|
| adam_text | CONTENTS XIII PREFACE TO THE SECOND, REVISED EDITION WIERSINGA, W.M.
(AMSTERDAM); KAHALY, GJ. (MAINZ) XIV PREFACE TO THE FIRST EDITION
WIERSINGA, W.M. (AMSTERDAM); KAHALY, GJ. (MAINZ) DIAGNOSIS AND
PATHOGENESIS I CLINICAL MANIFESTATIONS DICKINSON, A.J. (NEWCASTLE UPON
TYNE) 1 WHAT ARE THE COMMON SYMPTOMS OF GRAVES ORBITOPATHY? 1 WHAT ARE
THE COMMON SIGNS OF GRAVES ORBITOPATHY? 2 WHAT SIGNS ARE UNUSUAL IN
GRAVES ORBITOPATHY? 3 ARE THERE RACIAL DIFFERENCES IN HOW
GRAVES ORBITOPATHY MANIFESTS? 4 IS THE PRESENTATION OF GRAVES
ORBITOPATHY DIFFERENT IN OLDER COMPARED TO YOUNGER PATIENTS? 4 WHY CAN
THE CLINICAL PRESENTATION OF GRAVES ORBITOPATHY BE SO VARIABLE? 5 CAN
YOU GIVE ME A SHORT MECHANISTIC EXPLANATION FOR ALL THESE CLINICAL
MANIFESTATIONS? 6 WHAT DO THE TERMS ACTIVITY AND SEVERITY DENOTE? 6
WHY IS IT IMPORTANT TO DISTINGUISH ACTIVITY AND SEVERITY WHEN EVALUATING
PATIENTS? 7 WHAT SYMPTOMS AND SIGNS ARE VALUABLE FOR ASSESSING ACTIVITY?
7 HOW ARE THESE SIGNS ASSESSED? 9 HOW REPRODUCIBLE ARE THESE
ASSESSMENTS? 10 WHAT VALUE DOES THE CLINICAL ACTIVITY SCORE HAVE? 11 DO
PATIENTS WITHOUT SIGNS OF ACTIVITY EVER HAVE ACTIVE DISEASE? 12 WHAT
SHOULD I DO IF I AM NOT SURE WHETHER THE DISEASE IS ACTIVE? 12 ARE THERE
ANY OTHER WAYS TO EVALUATE ACTIVITY OTHER THAN CLINICAL EXAMINATION? 12
WHEN SHOULD THESE OTHER METHODS FOR ASSESSING ACTIVITY BE USED IN
ROUTINE CLINICAL PRACTICE? 1 BIBLIOGRAFISCHE INFORMATIONEN
HTTP://D-NB.INFO/1003053637 DIGITALISIERT DURCH 26 ORBIT-THYROID
RELATIONSHIP LAZARUS, J.H. (CARDIFF); MARINO, M. (PISA) 26 SHOULDTHIS
CONDITION ALWAYS BE CALLED GRAVES ORBITOPATHY? 26 DOES GRAVES
ORBITOPATHY OCCUR IN THE ABSENCE OF HYPERTHYROIDISM? 28 DO ALL PATIENTS
WITH GRAVES DISEASE HAVE GRAVES ORBITOPATHY? 28 WHAT COMES FIRST IN
GRAVES DISEASE? THE EYE CHANGES OR THE HYPERTHYROID SYMPTOMS? 29 DO TSH
RECEPTOR ANTIBODIES ALSO CAUSE GO? 30 ARE THERE ANY OTHER EXTRATHYROIDAL
MANIFESTATIONS OF GRAVES DISEASE APART FROM GRAVES ORBITOPATHY? 31
REFERENCES 33 EPIDEMIOLOGY DATIMENE, C (BRUSSELS) 33 WHAT IS THE PRESENT
ESTIMATED PREVALENCE OF GRAVES ORBITOPATHY? HAS IT CHANGED OVER THE LAST
DECADE? 34 IS THE AGE AND SEX DISTRIBUTION OF GRAVES ORBITOPATHY SIMILAR
TO THAT OF GRAVES DISEASE? 34 ARE THERE ETHNIC DIFFERENCES? 34 WHAT ARE
THE RISK FACTORS FOR THE OCCURRENCE OF GRAVES ORBITOPATHY? 35 IS
TOBACCO BAD FOR GRAVES ORBITOPATHY? 36 IS OCULAR CO-MORBIDITY RELEVANT
FOR GRAVES ORBITOPATHY? 36 IS ELEVATED INTRAOCULAR PRESSURE RELEVANT IN
GRAVES ORBITOPATHY? 37 IS THERE SIGNIFICANT NON-OCULAR CO-MORBIDITY
(LIKE DIABETES) WHICH IS RELEVANT FOR GRAVES ORBITOPATHY? 38 REFERENCES
40 PATHOGENESIS ORGIAZZI, J. (PIERRE-BENITE); LUDGATE, M. (CARDIFF) 40
WHAT ARE THE PATHOLOGICAL CHANGES IN ORBITAL TISSUE IN
GRAVES ORBITOPATHY? 42 HOW DO THE PATHOLOGICAL CHANGES GIVE RISE TO THE
CLINICAL MANIFESTATIONS? 4 61 WHAT IS THE PLACE OF ORBITAL ULTRASOUND?
63 WHAT LESSONS CAN WE LEARN FROM ORBITAL OCTREOSCAN? 63 WHAT OTHER
IMAGING TECHNIQUES MAY BE USEFUL? 64 ACKNOWLEDGMENTS 64 REFERENCES 66
DIAGNOSIS AND DIFFERENTIAL DIAGNOSIS OF GRAVES ORBITOPATHY MOU RITS,
M.P. (AMSTERDAM) 66 CAN YOU GIVE AN OVERALL SCHEME FOR THE DIAGNOSIS OF
GRAVES ORBITOPATHY? 66 WHICH CLINICAL FINDINGS ARE HELPFUL IN MAKING A
DIAGNOSIS OF GRAVES ORBITOPATHY? 70 CAN ONE MAKE A DIAGNOSIS OF
GRAVES ORBITOPATHY BASED ON MEDICAL HISTORY AND CLINICAL PICTURE ALONE?
70 DO WE ALWAYS NEED TO ORDER THYROID AUTOANTIBODIES AND THYROID
FUNCTION TESTS? 71 WHICH IMAGING TECHNIQUE IS BEST TO MAKE A DIAGNOSIS
OF GRAVES ORBITOPATHY AND IS IMAGING ALWAYS REQUESTED? 72 WHICH ARE THE
MOST FREQUENT CONDITIONS MIMICKING GRAVES ORBITOPATHY? 75 CONCLUSION 75
REFERENCES 77 NATURAL HISTORY PEARCE, S.; KENDALL-TAYLOR, P. (NEWCASTLE
UPON TYNE) 77 DOES GRAVES ORBITOPATHY OCCUR AT THE SAMETIME AS
HYPERTHYROIDISM? 78 DOES RESTORING EUTHYROIDISM LEAD TO IMPROVEMENT IN
GRAVES ORBITOPATHY? 79 WHAT EFFECT MAY HYPOTHYROIDISM HAVE? 79 WHAT IS
THE TYPICAL COURSE OF THE DISEASE? 80 WHAT IS THE DIFFERENCE BETWEEN
ACTIVITY AND SEVERITY? 82 HOW DO YOU DETERMINE WHICH PHASE OF THE
DISEASE THE PATIENT IS DISPLAYING? 83 HOW DOES THE PHASE OF THE DISEASE
INFLUENCE CHOICE OF TREATMENT? 83 WILL THE GO EVENTUALLY BURN ITSELF
OUT? 84 WILL THE ORBITAL CHANGES RETURN TO NORMAL WHEN THE CONDITION
EVENTUALLY RESOLVES? 8 96 COMBINED THYROID-EYE CLINICS WIERSINGA, W.M.
(AMSTERDAM) 96 WHAT ARE COMBINED THYROID-EYE CLINICS? 97 WHY IS A
MULTIDISCIPLINARY APPROACH RECOMMENDED? 98 CAN PATIENT-SUPPORT GROUPS BE
HELPFUL? 98 I HAVE HEARD OF A FAST-TRACK CLINIC FOR GRAVES ORBITOPATHY
PATIENTS: WHAT IS THAT? 99 REFERENCES LOO THYROID TREATMENT MARCOCCI, C;
PINCHERA, A. (PISA) 100 DOES IT MATTER FOR THE EYES HOW THE PATIENT IS
RENDERED EUTHYROID? 103 ARE THERE ANY SPECIFIC CRITERIA TO PREFER ONE OF
THE TREATMENT MODALITIES FOR HYPERTHYROIDISM IN GRAVES ORBITOPATHY? 104
IS THERE ANY RISK FACTOR WHICH MAY PREDICT APPEARANCE OR WORSENING OF
GRAVES ORBITOPATHY AFTER RADIOIODINE? 105 SHOULD THE PRESENCE OF
GRAVES ORBITOPATHY LIMIT THE USE OF RADIOIODINE THERAPY? 107 DOES
TRANSIENT HYPOTHYROIDISM FOLLOWING THERAPY INFLUENCE THE COURSE OF
GRAVES ORBITOPATHY? 107 HAS TOTAL THYROID ABLATION A ROLE IN THE
MANAGEMENT OF HYPERTHYROIDISM IN GRAVES ORBITOPATHY? 109 REFERENCES 111
MANAGEMENT OF MILD GRAVES ORBITOPATHY SALVI, M.; CURRO, N. (MILAN) 111
WHAT IS THE DEGREE OF INTRA-ORBITAL INVOLVEMENT IN MILD
GRAVES ORBITOPATHY? 111 ARE MILD FORMS OF GRAVES ORBITOPATHY LIKELY TO
PROGRESS TO MORE SEVERE GRAVES ORBITOPATHY? 112 IS A WAIT AND SEE POLICY
JUSTIFIED IN MILD GRAVES ORBITOPATHY? 114 ARE LOW-DOSAGE ORAL STEROIDS
ADVISABLE OR IS ORBITAL IRRADIATION PREFERABLE? 11 159 MANAGEMENT OF
VERY SEVERE GRAVES ORBITOPATHY (DYSTHYROID OPTIC NEUROPATHY AND CORNEAL
BREAKDOWN) LANE, CM. (CARDIFF); BOSCHI, A. (BRUSSELS) 159 HOW DO YOU
DEFINE DYSTHYROID OPTIC NEUROPATHY? 159 ARE THERE SPECIFIC RISK FACTORS
FOR DYSTHYROID OPTIC NEUROPATHY? 160 WHICH SYMPTOMS SHOULD ALERT ME? 161
WHAT ARE THE OPHTHALMOLOGICAL SIGNS OF DYSTHYROID OPTIC NEUROPATHY? 161
ARE ADDITIONAL INVESTIGATIONS HELPFUL? 162 HOW FAST CAN DYSTHYROID OPTIC
NEUROPATHY DEVELOP? IS URGENT TREATMENT NECESSARY? 163 WHAT IS THE
EVIDENCE BASE FOR THETREATMENT OF DYSTHYROID OPTIC NEUROPATHY? 163 WHAT
IS THE ROLE OF SURGERY IN DYSTHYROID OPTIC NEUROPATHY? 164 HOW MANY
PATIENTS BECOME BLIND DUE TO DYSTHYROID OPTIC NEUROPATHY? 164 HOW CAN I
RECOGNIZE CORNEAL BREAKDOWN? 164 WHAT IS THE RECOMMENDED TREATMENT OF
CORNEAL BREAKDOWN? 165 REFERENCES 167 REHABILITATIVE SURGERY BALDESCHI,
L (AMSTERDAM) 167 WHY IS THIS CHAPTER CALLED REHABILITATIVE SURGERY AND
NOT COSMETIC SURGERY? 168 WHAT ARE THE STEPS AND TIMING OF
REHABILITATIVE SURGERY? 169 HOW SHOULD PATIENTS BE SELECTED FOR
REHABILITATIVE SURGERY? 170 REFERENCES 171 ORBITAL DECOMPRESSION
BALDESCHI, L (AMSTERDAM) 171 WHAT IS ORBITAL DECOMPRESSION? 171 WHAT ARE
THE AIMS OF ORBITAL DECOMPRESSION? 175 WHICH SURGICAL TECHNIQUE SHOULD
BE PREFERRED? 183 WHAT ARE THE POSSIBLE COMPLICATIONS OF ORBITAL
DECOMPRESSION? 184 CAN COMPLICATIONS BE PREDICTED OR PREVENTED? 18 202
IS SURGICAL INTERVENTION INDICATED IN CORNEAL ULCERATION SECONDARY TO
EXPOSURE KERATOPATHY? 203 DOES ORBITAL DECOMPRESSION HAVE ANY EFFECT ON
LID RETRACTION? 203 DOES SQUINT SURGERY INFLUENCE THE LID CONFIGURATION?
204 WHAT SURGICAL PROCEDURES ARE AVAILABLE FOR CORRECTION OF UPPER LID
RETRACTION? 207 ARE THERE COMPLICATIONS? 207 WHAT SURGICAL PROCEDURES
ARE AVAILABLE FOR CORRECTION OF LOWER LID RETRACTION? 207 SHOULD THIS BE
COMBINED WITH HORIZONTAL LID TIGHTENING? 208 WHICH MATERIALS ARE
SUITABLE FOR USE AS SPACERS? SHOULD THE USE OF ALLOGENEIC GRAFTS BE
AVOIDED? 209 ARE THERE COMPLICATIONS? 209 WHAT ABOUT UPPER LID DEBULKING
AND UPPER AND LOWER LID BLEPHAROPLASTY? 209 REFERENCES MISCELLANEOUS
ISSUES 211 QUALITY OF LIFE WIERSINGA, W.M. (AMSTERDAM) 211 WHAT IS
QUALITY OF LIFE? 211 WHAT IS THE USEFULNESS OF QUALITY OF LIFE
MEASUREMENTS? 213 WHAT IS KNOWN ABOUT GENERAL HEALTH-RELATED QUALITY OF
LIFE IN GRAVES ORBITOPATHY? 214 ISTHERE A GO-SPECIFIC QUALITY OF LIFE
QUESTIONNAIRE? 216 WHAT ARE THE RESULTS OF THE GO-QOL? 216 CAN YOU
EXPLAIN RESPONSE SHIFT IN QUALITY OF LIFE? 217 CAN GO-QOL BE USED AS A
SEPARATE OUTCOME MEASUREMENT IN GO? 218 IS QUALITY OF LIFE FULLY
RESTORED AFTER TREATMENT OF GO? 219 CAN I APPLY THE GO-QOL IN MY OWN
PRACTICE? 219 REFERENCES 221 SOCIOECONOMIC IMPACT KAHALY, GJ. (MAINZ)
221 ISTHERE AN ACTUAL COST ESTIMATION OF THYROID DISORDERS IN GERMANY
AND/OR EUROPE? 22 236 WHAT IS GLOBE SUBLUXATION? 237 REFERENCES 239
CHILDHOOD GRAVES ORBITOPATHY KRASSAS, G.E. (THESSALONIKI) 239 IS
CHILDHOOD GRAVES ORBITOPATHY REALLY THAT RARE? 241 IS THE CLINICAL
PRESENTATION OF GRAVES ORBITOPATHY IN CHILDHOOD DIFFERENT FROM THAT IN
ADULTHOOD? 242 WHY IS GRAVES ORBITOPATHY N CHILDREN LESS SEVERE THAN
IN ADULTS? 243 WHAT IS THE BEST THERAPEUTIC APPROACH FOR
GRAVES ORBITOPATHY IN CHILDREN AND ADOLESCENTS? 245 WHAT ABOUT SURGICAL
DECOMPRESSION OF THE ORBIT IN CHILDHOOD? 245 REFERENCES 248 PREVENTION
BARTALENA, L (VARESE) 248 WHAT IS PRIMARY, SECONDARY AND TERTIARY
PREVENTION? 248 CAN A GENERAL STRATEGY BE APPLIED TO PREVENT
GRAVES ORBITOPATHY? 249 WHAT CAN BE DONE IN THE PRIMARY PREVENTION OF
GRAVES ORBITOPATHY? 250 WHAT CAN BE DONE IN TERMS OF SECONDARY
PREVENTION OF GRAVES ORBITOPATHY? 252 WHAT ABOUT TERTIARY PREVENTION OF
GRAVES ORBITOPATHY? 252 WHAT SHOULD ONE DO WHEN TALKING TO A GRAVES
ORBITOPATHY PATIENT WHO SMOKES? 253 ACKNOWLEDGEMENTS 253 REFERENCES 255
FUTURE DEVELOPMENTS SALVI, M. (MILAN); BALDESCHI, L (AMSTERDAM) 255 IS
THERE EVIDENCE THAT STEROIDS IN GRAVES ORBITOPATHY ACT AS TRUE
IMMUNOSUPPRESSANTS AND MODIFY DISEASE OUTCOME? 256 WHAT ARE THE REASONS
FOR EXPLORING THE POTENTIAL EFFICACY OF NEW IMMUNOSUPPRESSIVE
MEDICATIONS? 256 ISTHERE EVIDENCE FOR THE EFFICACY OF NEW IMMUNOTHERAPY
AGENTS IN GRAVES ORBITOPATHY 271 HISTORICAL NOTES ON GRAVES DISEASE
MOUNTS, M.P. (AMSTERDAM) 271 IS IT FAIR TO CALL
GRAVES DISEASE GRAVES DISEASE ? 272 VARIOUS EYE SIGNS CARRY SPECIFIC
NAMES: ARE THEY STILL RELEVANT? 272 HOW DID OLD THEORIES EXPLAIN THE
RELATIONSHIP BETWEEN HYPERTHYROIDISM AND PROPTOSIS? 274 WHAT ARE
RUNDLE S CONTRIBUTIONS TO OUR UNDERSTANDING OF GRAVES ORBITOPATHY? 276
WHAT ARE KRISS CONTRIBUTIONS TO THE MANAGEMENT OF GRAVES ORBITOPATHY?
278 WHEN WAS EVIDENCE-BASED MEDICINE INCORPORATED IN GRAVES ORBITOPATHY?
278 REFERENCES 280 AUTHOR INDEX 281 SUBJECT INDEX XII CONTENTS
|
| any_adam_object | 1 |
| building | Verbundindex |
| bvnumber | BV036657087 |
| classification_rvk | YO 3647 |
| ctrlnum | (OCoLC)671344907 (DE-599)DNB1003053637 |
| dewey-full | 617.74 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 617 - Surgery & related medical specialties |
| dewey-raw | 617.74 |
| dewey-search | 617.74 |
| dewey-sort | 3617.74 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| edition | 2., rev. ed. |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01591nam a2200421 c 4500</leader><controlfield tag="001">BV036657087</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20101221 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">100907s2010 gw ad|| |||| 00||| eng d</controlfield><datafield tag="015" ind1=" " ind2=" "><subfield code="a">10,N23</subfield><subfield code="2">dnb</subfield></datafield><datafield tag="016" ind1="7" ind2=" "><subfield code="a">1003053637</subfield><subfield code="2">DE-101</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9783805595315</subfield><subfield code="9">978-3-8055-9531-5</subfield></datafield><datafield tag="024" ind1="3" ind2=" "><subfield code="a">9783805595315</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)671344907</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DNB1003053637</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="044" ind1=" " ind2=" "><subfield code="a">gw</subfield><subfield code="c">XA-DE-BW</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-12</subfield><subfield code="a">DE-355</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">617.74</subfield><subfield code="2">22/ger</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">YO 3647</subfield><subfield code="0">(DE-625)153942:12954</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">610</subfield><subfield code="2">sdnb</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Graves' orbitopathy</subfield><subfield code="b">a multidisciplinary approach - questions and answers ; 41 tables</subfield><subfield code="c">ed.: Wilmar M. Wiersinga ...</subfield></datafield><datafield tag="250" ind1=" " ind2=" "><subfield code="a">2., rev. ed.</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Basel [u.a.]</subfield><subfield code="b">Karger</subfield><subfield code="c">2010</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">XV, 285 S.</subfield><subfield code="b">Ill., graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Endokrine Ophthalmopathie</subfield><subfield code="0">(DE-588)4196103-1</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)4143413-4</subfield><subfield code="a">Aufsatzsammlung</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Endokrine Ophthalmopathie</subfield><subfield code="0">(DE-588)4196103-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Wiersinga, Wilmar M.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Online-Ausgabe</subfield><subfield code="z">978-3-8055-9532-2</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">DNB Datenaustausch</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=020576468&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-020576468</subfield></datafield></record></collection> |
| genre | (DE-588)4143413-4 Aufsatzsammlung gnd-content |
| genre_facet | Aufsatzsammlung |
| id | DE-604.BV036657087 |
| illustrated | Illustrated |
| indexdate | 2024-07-09T22:45:05Z |
| institution | BVB |
| isbn | 9783805595315 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-020576468 |
| oclc_num | 671344907 |
| open_access_boolean | |
| owner | DE-12 DE-355 DE-BY-UBR |
| owner_facet | DE-12 DE-355 DE-BY-UBR |
| physical | XV, 285 S. Ill., graph. Darst. |
| publishDate | 2010 |
| publishDateSearch | 2010 |
| publishDateSort | 2010 |
| publisher | Karger |
| record_format | marc |
| spelling | Graves' orbitopathy a multidisciplinary approach - questions and answers ; 41 tables ed.: Wilmar M. Wiersinga ... 2., rev. ed. Basel [u.a.] Karger 2010 XV, 285 S. Ill., graph. Darst. txt rdacontent n rdamedia nc rdacarrier Endokrine Ophthalmopathie (DE-588)4196103-1 gnd rswk-swf (DE-588)4143413-4 Aufsatzsammlung gnd-content Endokrine Ophthalmopathie (DE-588)4196103-1 s DE-604 Wiersinga, Wilmar M. Sonstige oth Erscheint auch als Online-Ausgabe 978-3-8055-9532-2 DNB Datenaustausch application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=020576468&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis |
| spellingShingle | Graves' orbitopathy a multidisciplinary approach - questions and answers ; 41 tables Endokrine Ophthalmopathie (DE-588)4196103-1 gnd |
| subject_GND | (DE-588)4196103-1 (DE-588)4143413-4 |
| title | Graves' orbitopathy a multidisciplinary approach - questions and answers ; 41 tables |
| title_auth | Graves' orbitopathy a multidisciplinary approach - questions and answers ; 41 tables |
| title_exact_search | Graves' orbitopathy a multidisciplinary approach - questions and answers ; 41 tables |
| title_full | Graves' orbitopathy a multidisciplinary approach - questions and answers ; 41 tables ed.: Wilmar M. Wiersinga ... |
| title_fullStr | Graves' orbitopathy a multidisciplinary approach - questions and answers ; 41 tables ed.: Wilmar M. Wiersinga ... |
| title_full_unstemmed | Graves' orbitopathy a multidisciplinary approach - questions and answers ; 41 tables ed.: Wilmar M. Wiersinga ... |
| title_short | Graves' orbitopathy |
| title_sort | graves orbitopathy a multidisciplinary approach questions and answers 41 tables |
| title_sub | a multidisciplinary approach - questions and answers ; 41 tables |
| topic | Endokrine Ophthalmopathie (DE-588)4196103-1 gnd |
| topic_facet | Endokrine Ophthalmopathie Aufsatzsammlung |
| url | http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=020576468&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |
| work_keys_str_mv | AT wiersingawilmarm gravesorbitopathyamultidisciplinaryapproachquestionsandanswers41tables |